β-lactamase inhibitors display anti-seizure properties in an invertebrate assay

Neuroscience

Volumn 169, Issue 4, 2010, Pages 1800-1804

  Rawls, S M ^a   Karaca, F ^a   Madhani, I ^a   Bhojani, V ^a   Martinez, R L ^a,b   Abou Gharbia, M ^a,b   Raffa, R B ^a  

^a Temple University Health Sciences Center   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF PHARMACY   (United States)

Author keywords

Ceftriaxone; Clavulanic acid; Glutamate; Planaria; Tazobactam; lactam antibiotic

Indexed keywords

BETA LACTAMASE INHIBITOR; CEFTRIAXONE; CLAVULANIC ACID; COCAINE; GLUTAMIC ACID; TAZOBACTAM; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC THERAPY; ANTICONVULSANT ACTIVITY; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG DETERMINATION; DRUG EFFICACY; DRUG PENETRATION; DRUG TOLERABILITY; IC 50; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; SEIZURE; TURBELLARIA;

EID: 77955413383     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2010.06.041     Document Type: Article

References (22)

1. Bolton G.C., Allen G.D., Davies B.E., Filer C.W., Jeffery D.J. The disposition of clavulanic acid in man. Xenobiotica 1986, 16:853-863.
2. Buttarelli F.R., Pontieri F.E., Margotta V., Palladini G. Acetylcholine/dopamine interaction in planaria. Comp Biochem Physiol C Toxicol Pharmacol 2000, 125:225-231.
3. Campbell S.L., Hablitz J.J. Decreased glutamate transport enhances excitability in a rat model of cortical dysplasia. Neurobiol Dis 2008, 32:254-261.
4. Chu K., Lee S.T., Sinn D.I., Ko S.Y., Kim E.H., Kim J.M., Kim S.J., Park D.K., Jung K.H., Song E.C., Lee S.K., Kim M., Roh J.K. Pharmacological induction of ischemic tolerance by glutamate transporter-1 (EAAT2) upregulation. Stroke 2007, 38:177-182.
5. Eriksson K.S., Panula P. gamma-Aminobutyric acid in the nervous system of a planarian. J Comp Neurol 1994, 345:528-536.
6. Guo F., Sun F., Yu J.L., Wang Q.H., Tu D.Y., Mao X.Y., Liu R., Wu K.C., Xie N., Hao L.Y., Cai J.Q. Abnormal expressions of glutamate transporters and metabotropic glutamate receptor 1 in the spontaneously epileptic rat hippocampus. Brain Res Bull 2010, 81:510-516.
7. Jelenkovic A.V., Jovanovic M.D., Stanimirovic D.D., Bokonjic D.D., Ocic G.G., Boskovic B.S. Beneficial effects of ceftriaxone against pentylenetetrazole-evoked convulsions. Exp Biol Med 2008, 233:1389-1394.
8. Knackstedt L.A., Melendez R.I., Kalivas P.W. Ceftriaxone restores glutamate homeostasis and prevents relapse to cocaine seeking. Biol Psychiatry 2010, 67:81-84.
9. Lipski J., Wan C.K., Bai J.Z., Pi R., Li D., Donnelly D. Neuroprotective potential of ceftriaxone in in vitro models of stroke. Neuroscience 2007, 146:617-629.
10. Miller B.R., Dorner J.L., Shou M., Sari Y., Barton S.J., Sengelaub D.R., Kennedy R.T., Rebec G.V. Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington's disease phenotype in the R6/2 mouse. Neuroscience 2008, 153:329-337.
11. Nakagawa H., Yamada M., Tokiyoshi K., Miyawaki Y., Kanayama T. Penetration of potassium clavulanate/ticarcillin sodium into cerebrospinal fluid in neurosurgical patients. Jpn J Antibiot 1994, 47:93-101.
12. Pagán O.R., Rowlands A.L., Azam M., Urban K.R., Bidja A.H., Roy D.M., Feeney R.B., Afshari L.K. Reversal of cocaine-induced planarian behavior by parthenolide and related sesquiterpene lactones. Pharmacol Biochem Behav 2008, 89:160-170.
13. Palladini G., Ruggeri S., Stocchi F., De Pandis M.F., Venturini G., Margotta V. A pharmacological study of cocaine activity in planaria. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 1996, 115:41-45.
14. Passarelli F., Merante A., Pontieri F.E., Margotta V., Venturini G., Palladini G. Opioid-dopamine interaction in planaria: a behavioral study. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 1999, 124:51-55.
15. Rawls S.M., Gomez T., Raffa R.B. An NMDA antagonist (LY 235959) attenuates abstinence-induced withdrawal of planarians following acute exposure to a cannabinoid agonist (WIN 55212-2). Pharmacol Biochem Behav 2007, 86:499-504.
16. Rawls S.M., Gomez T., Stagliano G.W., Raffa R.B. Measurement of glutamate and aspartate in planaria. J Pharmacol Toxicol Methods 2006, 53:291-295.
17. Rawls S.M., Thomas T., Adeola M., Patil T., Raymondi N., Poles A., Loo M., Raffa R.B. Topiramate antagonizes NMDA- and AMPA-induced seizure-like activity in planarians. Pharmacol Biochem Behav 2009, 93:363-367.
18. Rawls S.M., Zielinski M., Patel H., Sacavage S., Baron D.A., Patel D. Beta-lactam antibiotic reduces morphine analgesic tolerance in rats through GLT-1 transporter activation. Drug Alcohol Depend 2010, 107:261-263.
19. Rawls S.M., Baron D.A., Kim J. β-lactam antibiotic inhibits development of morphine physical dependence in rats. Behav Pharmacol 2010, 21:161-164.
20. Rothstein J.D., Patel S., Regan M.R., Haenggeli C., Huang Y.H., Bergles D.E., Jin L., Dykes Hoberg M., Vidensky S., Chung D.S., Toan S.V., Bruijn L.I., Su Z.Z., Gupta P., Fisher P.B. Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 2005, 433:73-77.
21. Sari Y., Smith K.D., Ali P.K., Rebec G.V. Upregulation of GLT-1 attenuates cue-induced reinstatement of cocaine-seeking behavior in rats. J Neurosci 2009, 29:9239-9243.
22. Sheldon A.L., Robinson M.B. The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention. Neurochem Int 2007, 51:333-355.